Teresa Y. Basham
About
In The Last Decade
Teresa Y. Basham
28 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Immunology 1.0k
- Radiology, Nuclear Medicine and Imaging 387
- Molecular Biology 303
- Oncology 249
- Epidemiology 217
Countries citing papers authored by Teresa Y. Basham
This map shows the geographic impact of Teresa Y. Basham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Y. Basham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Y. Basham more than expected).
Fields of papers citing papers by Teresa Y. Basham
This network shows the impact of papers produced by Teresa Y. Basham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Y. Basham. The network helps show where Teresa Y. Basham may publish in the future.
Co-authorship network of co-authors of Teresa Y. Basham
This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Y. Basham. A scholar is included among the top collaborators of Teresa Y. Basham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Y. Basham. Teresa Y. Basham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 16 | |
| 3 | 27 | |
| 4 | 6 | |
| 5 | Enhanced in vivo therapeutic response to interferon in mice with an in vitro interferon-resistant B-cell lymphoma. | 9 |
| 6 | 135 | |
| 7 | 18 | |
| 8 | Comparison of combinations of interferons with tumor specific and nonspecific monoclonal antibodies as therapy for murine B- and T-cell lymphomas. | 10 |
| 9 | 29 | |
| 10 | 32 | |
| 11 | 66 | |
| 12 | 4 | |
| 13 | 91 | |
| 14 | 37 | |
| 15 | 26 | |
| 16 | Recombinant interferon-gamma increases HLA-DR synthesis and expression. breakdown → | 504 |
| 17 | 6 | |
| 18 | 8 | |
| 19 | 11 | |
| 20 | 54 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.